CHINA PHARMA HOLDINGS, INC. Quarterly Debt-to-equity in % from Q1 2012 to Q4 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
China Pharma Holdings, Inc. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q4 2023.
  • China Pharma Holdings, Inc. Debt-to-equity for the quarter ending December 31, 2023 was 187 %, a 45.3% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2023 187 -155 -45.3% Dec 31, 2023
Q3 2023 241 -86.3 -26.4% Sep 30, 2023
Q2 2023 315 +56.4 +21.8% Jun 30, 2023
Q1 2023 338 +107 +46.4% Mar 31, 2023
Q4 2022 342 +139 +68.2% Dec 31, 2022
Q3 2022 327 +150 +84.8% Sep 30, 2022
Q2 2022 259 +81.3 +45.8% Jun 30, 2022
Q1 2022 231 +59.5 +34.7% Mar 31, 2022
Q4 2021 204 +34.4 +20.3% Dec 31, 2021
Q3 2021 177 +14.4 +8.87% Sep 30, 2021
Q2 2021 178 +75.7 +74.3% Jun 30, 2021
Q1 2021 171 +98.7 +136% Mar 31, 2021
Q4 2020 169 +113 +200% Dec 31, 2020
Q3 2020 163 +114 +238% Sep 30, 2020
Q2 2020 102 +55.7 +121% Jun 30, 2020
Q1 2020 72.6 +28.1 +63.3% Mar 31, 2020
Q4 2019 56.4 +14 +32.9% Dec 31, 2019
Q3 2019 48.2 +7.99 +19.9% Sep 30, 2019
Q2 2019 46.1 +8.51 +22.6% Jun 30, 2019
Q1 2019 44.4 +8.5 +23.6% Mar 31, 2019
Q4 2018 42.4 +7.86 +22.7% Dec 31, 2018
Q3 2018 40.2 +6.78 +20.3% Sep 30, 2018
Q2 2018 37.6 +3.45 +10.1% Jun 30, 2018
Q1 2018 36 +1.11 +3.19% Mar 31, 2018
Q4 2017 34.6 -0.71 -2.01% Dec 31, 2017
Q3 2017 33.4 -1.69 -4.82% Sep 30, 2017
Q2 2017 34.2 -1.02 -2.9% Jun 30, 2017
Q1 2017 34.8 +0.67 +1.96% Mar 31, 2017
Q4 2016 35.3 +1.62 +4.81% Dec 31, 2016
Q3 2016 35.1 +2.07 +6.27% Sep 30, 2016
Q2 2016 35.2 +5.75 +19.5% Jun 30, 2016
Q1 2016 34.2 +8.04 +30.8% Mar 31, 2016
Q4 2015 33.7 +10.9 +47.9% Dec 31, 2015
Q3 2015 33 +12.8 +63.5% Sep 30, 2015
Q2 2015 29.4 +11.5 +64.2% Jun 30, 2015
Q1 2015 26.1 +10.9 +71.2% Mar 31, 2015
Q4 2014 22.8 +10.1 +79.9% Dec 31, 2014
Q3 2014 20.2 +9.58 +90.3% Sep 30, 2014
Q2 2014 17.9 +7.92 +79.3% Jun 30, 2014
Q1 2014 15.3 +4.98 +48.5% Mar 31, 2014
Q4 2013 12.7 +1.58 +14.3% Dec 31, 2013
Q3 2013 10.6 -0.44 -3.98% Sep 30, 2013
Q2 2013 9.99 -0.69 -6.46% Jun 30, 2013
Q1 2013 10.3 +0.04 +0.39% Mar 31, 2013
Q4 2012 11.1 Dec 31, 2012
Q3 2012 11.1 Sep 30, 2012
Q2 2012 10.7 Jun 30, 2012
Q1 2012 10.2 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.